Crystal structure of MexZ, a key repressor responsible for antibiotic resistance in Pseudomonas aeruginosa

Journal of Structural Biology

Volumn 172, Issue 3, 2010, Pages 305-310

  Alguel, Yilmaz ^a   Lu, Duo ^a   Quade, Nick ^a   Sauter, Sebastian ^a   Zhang, Xiaodong ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Antibiotic resistance; Gene regulation; MexZ; Pseudomonas aeruginosa; TetR

Indexed keywords

BACTERIAL PROTEIN; MEXZ PROTEIN; TETR PROTEIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; CRYSTAL STRUCTURE; CRYSTALLIZATION; DNA BINDING; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; HUMAN; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; PSEUDOMONAS AERUGINOSA; REPRESSOR GENE;

BACTERIAL PROTEINS; CRYSTALLOGRAPHY, X-RAY; CYSTIC FIBROSIS; DNA; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; LUNG; MUTATION; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PSEUDOMONAS AERUGINOSA;

PSEUDOMONAS AERUGINOSA;

EID: 77958185365     PISSN: 10478477     EISSN: 10958657     Source Type: Journal    
DOI: 10.1016/j.jsb.2010.07.012     Document Type: Article

References (38)

1. Adams P.D., Grosse-Kunstleve R.W., Hung L.W., Ioerger T.R., McCoy A.J., Moriarty N.W., Read R.J., Sacchettini J.C., Sauter N.K., Terwilliger T.C. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D Biol. Crystallogr. 2002, 58(Pt. 11):1948-1954.
2. Aires J.R., Kohler T., Nikaido H., Plesiat P. Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob. Agents Chemother. 1999, 43(11):2624-2628.
3. Alguel Y., Meng C., Teran W., Krell T., Ramos J.L., Gallegos M.T., Zhang X. Crystal structures of multidrug binding protein TtgR in complex with antibiotics and plant antimicrobials. J. Mol. Biol. 2007, 369(3):829-840.
4. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S., Read R.J., Rice L.M., Simonson T., Warren G.L. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 1998, 54(5):905-921.
5. Emsley P., Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 2004, 60(Pt. 12, Pt.1):2126-2132.
6. Fluit A.C., Jones M.E., Schmitz F.J., Acar J., Gupta R., Verhoef J. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998. Clin. Infect. Dis. 2000, 30(3):454-460.
7. Foundation CF, 2002. Annual Report. Cystic Fibrosis Foundation, Bethesda.
8. Garau J., Gomez L. Pseudomonas aeruginosa pneumonia. Curr. Opin. Infect. Dis. 2003, 16(2):135-143.
9. Glupczynski Y., Delmee M., Goossens H., Struelens M. Distribution and prevalence of antimicrobial resistance among gram-negative isolates in intensive care units (ICU) in Belgian hospitals between 1996 and 1999. Acta Clin. Belg. 2001, 56(5):297-306.
10. Govan J.R., Brown A.R., Jones A.M. Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection. Future Microbiol. 2007, 2:153-164.
11. Govan J.R., Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 1996, 60(3):539-574.
12. Hancock R.E., Speert D.P. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment. Drug Resist. Updat. 2000, 3(4):247-255.
13. Hendrickson W.A., Horton J.R., LeMaster D.M. Selenomethionyl proteins produced for analysis by multiwavelength anomalous diffraction (MAD): a vehicle for direct determination of three-dimensional structure. EMBO J. 1990, 9(5):1665-1672.
14. Hinrichs W., Kisker C., Duvel M., Muller A., Tovar K., Hillen W., Saenger W. Structure of the Tet repressor-tetracycline complex and regulation of antibiotic resistance. Science 1994, 264(5157):418-420.
15. Jeannot K., Sobel M.L., El Garch F., Poole K., Plesiat P. Induction of the MexXY efflux pump in Pseudomonas aeruginosa is dependent on drug-ribosome interaction. J. Bacteriol. 2005, 187(15):5341-5346.
16. Jones T.A., Zou J.Y., Cowan S.W., Kjeldgaard Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 1991, 47(2):110-119.
17. Kabsch W. Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants. J. Appl. Cryst. 1993, 26:6.
18. Kohler T., Pechere J.C., Plesiat P. Bacterial antibiotic efflux systems of medical importance. Cell Mol. Life Sci. 1999, 56(9-10):771-778.
19. MacLeod D.L., Nelson L.E., Shawar R.M., Lin B.B., Lockwood L.G., Dirk J.E., Miller G.H., Burns J.L., Garber R.L. Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment. J. Infect. Dis. 2000, 181(3):1180-1184.
20. Matsuo Y., Eda S., Gotoh N., Yoshihara E., Nakae T. MexZ-mediated regulation of mexXY multidrug efflux pump expression in Pseudomonas aeruginosa by binding on the mexZ-mexX intergenic DNA. FEMS Microbiol. Lett. 2004, 238(1):23-28.
21. Morita Y., Sobel M.L., Poole K. Antibiotic inducibility of the MexXY multidrug efflux system of Pseudomonas aeruginosa: involvement of the antibiotic-inducible PA5471 gene product. J. Bacteriol. 2006, 188(5):1847-1855.
22. Phillips I., King A., Shannon K. Prevalence and mechanisms of aminoglycoside resistance. A ten-year study. Am. J. Med. 1986, 80(6B):48-55.
23. Poole K. Efflux-mediated multiresistance in Gram-negative bacteria. Clin. Microbiol. Infect. 2004, 10(1):12-26.
24. Poole K. Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 2005, 49(2):479-487.
25. Poole K., Srikumar R. Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance. Curr. Top. Med. Chem. 2001, 1(1):59-71.
26. Ramos J.L., Duque E., Gallegos M.T., Godoy P., Ramos-Gonzalez M.I., Rojas A., Teran W., Segura A. Mechanisms of solvent tolerance in gram-negative bacteria. Annu. Rev. Microbiol. 2002, 56:743-768.
27. Ramos J.L., Martinez-Bueno M., Molina-Henares A.J., Teran W., Watanabe K., Zhang X., Gallegos M.T., Brennan R., Tobes R. The TetR family of transcriptional repressors. Microbiol. Mol. Biol. Rev. 2005, 69(2):326-356.
28. Schumacher M.A., Miller M.C., Grkovic S., Brown M.H., Skurray R.A., Brennan R.G. Structural mechanisms of QacR induction and multidrug recognition. Science 2001, 294(5549):2158-2163.
29. Schweizer H.P. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions. Genet. Mol. Res. 2003, 2(1):48-62.
30. Smith E.E., Buckley D.G., Wu Z., Saenphimmachak C., Hoffman L.R., D'Argenio D.A., Miller S.I., Ramsey B.W., Speert D.P., Moskowitz S.M., Burns J.L., Kaul R., Olson M.V. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl. Acad. Sci. USA 2006, 103(22):8487-8492.
31. Teran W., Krell T., Ramos J.L., Gallegos M.T. Effector-repressor interactions, binding of a single effector molecule to the operator-bound TtgR homodimer mediates derepression. J. Biol. Chem. 2006, 281(11):7102-7109.
32. Terwilliger T.C. Maximum-likelihood density modification. Acta Crystallogr. D Biol. Crystallogr. 2000, 56(8):965-972.
33. Van Delden C., Iglewski B.H. Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerg. Infect. Dis. 1998, 4(4):551-560.
34. Vincent J.L. Microbial resistance: lessons from the EPIC study. European Prevalence of Infection. Intensive Care Med. 2000, 26(Suppl. 1):S3-S8.
35. Vincent J.L., Bihari D.J., Suter P.M., Bruining H.A., White J., Nicolas-Chanoin M.H., Wolff M., Spencer R.C., Hemmer M. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995, 274(8):639-644.
36. Vogne C., Aires J.R., Bailly C., Hocquet D., Plesiat P. Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob. Agents Chemother. 2004, 48(5):1676-1680.
37. Westbrock-Wadman S., Sherman D.R., Hickey M.J., Coulter S.N., Zhu Y.Q., Warrener P., Nguyen L.Y., Shawar R.M., Folger K.R., Stover C.K. Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability. Antimicrob. Agents Chemother. 1999, 43(12):2975-2983.
38. Yamamoto, M., Ueda, A., Kudo, M., Matsuo, Y., Fukushima, J., Nakae, T., Kaneko, T., Ishigatsubo, Y., 2009. Role of MexZ and PA5471 in transcriptional regulation of mexXY in Pseudomonas aeruginosa. Microbiology.